ESC Premium Access

PURE - Impact of modifiable risk factors on cardiovascular disease and mortality

Congress Presentation

About the speaker

Doctor Salim Yusuf

Population Health Research Institute, Hamilton (Canada)
26 presentations
0 follower

12 more presentations in this session

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommended therapies. Final 5-year results from the CLARIFY study

Speaker: Doctor E. Sorbets (Paris, FR)

Thumbnail

Discussant review - CLARIFY

Speaker: Professor D. Hasdai (Petah Tikva, IL)

Thumbnail

Questions from the audience and discussion

Thumbnail

SWEDEHEART - Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Speaker: Doctor E. Bjoerklund (Gothenburg, SE)

Thumbnail

Discussant review - SWEDEHEART

Speaker: Professor V. Falk (Berlin, DE)

Thumbnail

Access the full session

Hot Line Session 5

Speakers: Doctor S. Yusuf, Doctor E. Sorbets, Professor D. Hasdai, Doctor E. Bjoerklund, Professor V. Falk
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb